(Q53600002)

English

A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16966336

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

A novel positive feedback loop between peroxisome proliferator-activated receptor-delta and prostaglandin E2 signaling pathways for human cholangiocarcinoma cell growth. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16966336

cholangiocarcinoma

0 references

prostaglandin E2

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lihong Xu

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16966336

Chang Han

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16966336

Tong Wu

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16966336

language of work or name

0 references

publication date

11 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16966336

number of pages

15

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16966336

281

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16966336

45

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16966336

33982-33996

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16966336

Cholangiocarcinoma: Current concepts and insights

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

The molecular pathogenesis of cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Why there are two cyclooxygenase isozymes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Cyclooxygenases: structural, cellular, and molecular biology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Peroxisome proliferator-activated receptors: from genes to physiology

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Peroxisome proliferator-activated receptors, coactivators, and downstream targets

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

PPARgamma, the ultimate thrifty gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

PPARs and the complex journey to obesity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

PPARdelta is a very low-density lipoprotein sensor in macrophages

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Activation of peroxisome proliferator-activated receptor delta stimulates the proliferation of human breast and prostate cancer cell lines.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Regulated formation of eicosanoids

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Arachidonic acid, an omega-6 fatty acid, induces cytoplasmic phospholipase A2 in prostate carcinoma cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

85-kDa cPLA(2) plays a critical role in PPAR-mediated gene transcription in human hepatoma cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

85-kDa cytosolic phospholipase A2 mediates peroxisome proliferator-activated receptor gamma activation in human lung epithelial cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Feedback control of the arachidonate cascade in rheumatoid synoviocytes by 15-deoxy-Delta(12,14)-prostaglandin J2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Positive feedback regulation of COX-2 expression by prostaglandin metabolites

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Cytosolic phospholipase A2alpha regulates induction of brain cyclooxygenase-2 in a mouse model of inflammation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M600135200

21 January 2018

Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1002/JCP.20560

Identifiers

10.1074/JBC.M600135200

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16966336

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16966336

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53600002&oldid=2164719035"